These findings corroborate the central role of STAT3 and ERK1/2 activation in T-LGL leukemia and provide an explanation for STAT3 hyper-activation in STAT3 nonmutated patients. The gene discussed is MAPK3; the disease is T-cell large granular lymphocyte leukemia.